Glaucoma Therapeutics Market Growth Statistics,Size, SWOT Analysis, Forthcoming Developments, Upcoming Investments and Forecast 2018-2026

                                                                               
Glaucoma therapies refer to a variety of treatment methods for primary open-angle (POA) and primary angle-closure (PAC) glaucoma.

       Glaucoma Therapeutics Market



Glaucoma therapies refer to a variety of treatment methods for primary open-angle (POA) and primary angle-closure (PAC) glaucoma. The disorder is characterised by structural changes in the optic nerves, which frequently lead to vision loss and blindness. Glaucoma can be treated using topical eye drops that contain beta-blockers, prostaglandin analogues, cholinergic, carbonic anhydrase inhibitors, and alpha-adrenergic agonists. These eye drops lower intraocular pressure by reducing fluid production in the eyes (IOP). Following that, implanted extended-release devices, polymer-based contact lenses, drug-eluting punctal plugs, microneedle-injection devices, and micro-dosing technologies can be used to undertake traditional or laser surgical procedures, or a mix of both.


Glaucoma can affect both diabetics and non-diabetics. Furthermore, those with diabetic retinopathy are more likely to develop glaucoma. The issue is linked to aberrant blood vessel growth, which can lead to retinopathy and blocking of the eye's natural drainage. One of the major factors contributing to the rising prevalence of glaucoma is the rapidly growing geriatric population, which is expected to drive the Glaucoma Therapeutics Market in the near future. According to 2017 statistics from the International Diabetes Foundation (IDF), the number of people with diabetes aged 20 to 79 years is on the rise around the world.


Market Segmentation:

By Disease Type
  • Primary Open Angle Glaucoma (POAG)
  • Primary Angle Closure Glaucoma (PACG)

By Drug Class:
  • Alpha adrenergic Agonist
  • Beta Blockers
  • Prostaglandin Analogs
  • Carbonic Anhydrase Inhibitor
  • Cholinergic
  • Combined Medication
  • Fixed-dose Combinations

By End Users:
  • Hospitals
  • Ophthalmic Clinics
  • Ambulatory Surgical Centers
  • Others

One of the primary factors driving the market's growth is the rising prevalence of glaucoma around the world. Glaucoma is quite common among diabetics and people who have additional visual problems such age-related macular degeneration (AMD), cataracts, and dry eye. In accordance with this, the growing senior population, which is more vulnerable to such disorders, is boosting market growth prospects.


Some of the key players operating in the glaucoma therapeutics market include Valeant Pharmaceuticals International, Inc., Allergan Inc., Merck KGaA, Fera Pharmaceuticals, LLC, Teva Pharmaceutical Industries Ltd., Pfizer Inc., Aristo Pharmaceuticals Pvt. Ltd., Santen Pharmaceutical Co., Ltd., Aerie Pharmaceuticals, and Novartis AG.

Comments

Post a Comment

Popular posts from this blog

Flavors and Fragrances Market: A Comprehensive Analysis of Current Trends and Future Outlook

Image
  Flavors and Fragrances Market Introduction: The global flavors and fragrances market has witnessed remarkable growth in recent years, driven by increasing consumer preferences for enhanced sensory experiences in various industries. Flavors and fragrances play a vital role in food and beverages, personal care products, household products, and the pharmaceutical industry. This report provides an in-depth analysis of the flavors and fragrances market, highlighting key trends, market dynamics, and future prospects. Market Overview: The flavors and fragrances market has experienced substantial growth, with a projected CAGR of X% from 2023 to 2028. The market is primarily driven by rising disposable incomes, urbanization, and changing consumer lifestyles. Key market players are continually investing in research and development activities to introduce innovative flavors and fragrances that cater to evolving consumer demands. Segmentation and Key Market Players: The market can...
Read more

Exploring the Different Types of Blood Clotting Factors and Their Functions

Image
  Blood Clotting Factor Coagulation, another name for blood clotting, is a complicated process that is essential for reducing excessive bleeding after an injury. It entails a chain of events that cause a blood clot to develop, sealing the injured blood artery and stopping further bleeding. Blood clotting factors are a group of proteins that control these processes. Roman numerals from I to XIII are used to identify each of the 13 distinct blood clotting factors. The liver makes them, and platelets, the tiny blood cells that aid in blood clotting, also make some of them. Each of these elements interacts with the others in a series of reactions, activating the one before it. Factor I : Also known as fibrinogen, is a protein that is converted into fibrin, the main component of a blood clot. Factor II, also known as prothrombin, is converted into thrombin, which converts fibrinogen into fibrin. Factor III, also known as tissue factor, is released by damaged tissue and initiates the...
Read more

Global Orthopedic Imaging Market Size By Product, By Indication, By End User, Analysis And Forecast 2027

Image
                              Orthopedic Imaging Market Medical imaging in orthopaedics allows doctors to examine the interior architecture of the body non-invasively to aid in the diagnosis of a medical disease. Medical imaging technologies detect and track illnesses and injuries by providing pictures that represent the interior anatomical features of the patient's body. These gadgets are utilised as a knowledge tool to assist clinicians in determining the condition and its response to therapy. Orthopedic medical imaging provides clinicians with dependable, accessible, and high-quality imaging, which is an important criterion for medical decision-making and may lessen the need for surgical operations. Increased incidences of bone fracture trauma due to falls, motor vehicle accidents, or sports injuries necessitate prompt medical attention, which orthopaedic medical imaging systems may deliver. According to the ...
Read more